Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.
Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.


RARE DISEASE
Blue rubber bleb nevus
Blue rubber bleb nevus
Blue rubber bleb nevus
Synonyms: BRBN, Bean syndrome
Synonyms: BRBN, Bean syndrome
Synonyms: BRBN, Bean syndrome
Drug discovery
150
papers
On emerging therapies
Rare developmental defect during embryogenesis
Blue rubber bleb nevus
Overview
Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare congenital disorder characterized by multifocal venous malformations, primarily affecting the skin and gastrointestinal (GI) tract. Clinical hallmarks include GI bleeding, chronic iron deficiency anemia, and compressible blue-purple cutaneous lesions. Severe complications include life-threatening hemorrhage, intussusception, and volvulus. Diagnosis relies on clinical evaluation, endoscopy, and imaging. While supportive care is mainstay, targeted interventions may be required for refractory cases [1][2][12].
Categories: rare circulatory system diseases, rare developmental anomalies during embryogenesis, rare genetic diseases, rare neoplastic diseases, rare skin diseases
Research Papers
150 drug discovery papers about Blue rubber bleb nevus. Recent publications:
150 drug discovery papers about Blue rubber bleb nevus. Recent publications:
categories:
Small molecules
small molecules
2026-09-25 | When lesion-directed therapy is not enough: blue rubber bleb nevus syndrome in a young adult-a case report.
Blue rubber bleb nevus syndrome (BRBNS) is a rare systemic venous malformation disorder that primarily affects the skin and gastrointestinal tract. We report a 20-year-old Chinese man of Han ethnicity with multifocal cutaneous and soft-tissue venous malformations and recurrent gastrointestinal bleeding since early childhood. Despite repeated endoscopic and surgical interventions, he developed recurrent melena, hematochezia, and severe anemia requiring transfusion. During the current hospitalization, he received packed red-cell transfusion and oral iron supplementation and underwent lauromacrogol sclerotherapy of multiple symptomatic soft-tissue venous malformations. His hemoglobin level increased from 55 to 98 g/L at discharge, and no recurrent gastrointestinal bleeding occurred during 2 months of follow-up. This case illustrates the limitations of repeated lesion-directed therapy in multifocal BRBNS and emphasizes the importance of multidisciplinary management and longitudinal surveillance. Although early clinical and hematologic improvement was observed, longer follow-up is required to determine whether durable disease control has been achieved.
2026-09-09 | Blue rubber bleb nevus syndrome as an uncommon cause of gastrointestinal overt bleeding: a diagnostic and therapeutic challenge.
A 76-year-old woman on anticoagulation for atrial fibrillation presented with melaena. Her medical history included previous jejunal resection, aortic aneurysm repair, and cervical cancer in remission. Initial upper gastrointestinal endoscopy and complete colonoscopy showed no source of bleeding. Despite discontinuation of anticoagulation, she developed recurrent gastrointestinal bleeding with severe transfusion-dependent anaemia. Capsule endoscopy demonstrated bluish submucosal vascular lesions in the jejunum, suggestive of Blue Rubber Bleb Nevus Syndrome (BRBNS), a diagnosis further supported by dermatological findings. Single-balloon enteroscopy revealed multiple jejunal venous blebs, with no active bleeding, throughout the first 240 cm of examined small bowel. Treatment with somatostatin and sirolimus was started; however, ongoing bleeding and clinical instability prompted an enteroscopy-guided surgical strategy. At laparotomy, multiple subserosal jejunal lesions were identified, corresponding to the endoscopic findings. A 20-cm bleeding jejunal segment was resected, followed by end-to-end anastomosis, with preservation of 250 cm of jejunum. BRBNS, also known as Bean syndrome, is a rare vascular malformation disorder characterised by multiple venous malformations, most commonly affecting the skin and gastrointestinal tract. Gastrointestinal involvement may lead to chronic occult bleeding, recurrent overt haemorrhage, iron-deficiency anaemia, and transfusion dependence. Current evidence is largely limited to case reports and small series, making management challenging. Endoscopic therapy is generally preferred when lesions are accessible, but extensive or multifocal small-bowel disease may limit its effectiveness. Sirolimus has shown promising results as systemic therapy, although its delayed onset of action may be unsuitable in patients with severe ongoing haemorrhage or clinical instability. This case highlights the value of capsule endoscopy and device-assisted enteroscopy not only for diagnosing small-bowel BRBNS, but also for guiding bowel-sparing surgery when endoscopic treatment is insufficient and systemic therapy cannot provide timely haemorrhage control.
2026-09-01 | Transitioning Care in Blue Rubber Bleb Nevus Syndrome
Blue rubber bleb nevus syndrome (BRBNS) is a rare venous malformation disorder characterized by multifocal cutaneous and visceral lesions, most commonly involving the gastrointestinal tract. These lesions may cause chronic occult bleeding, iron-deficiency anemia, pain crises, and occasionally life-threatening hemorrhage. Sirolimus, an mechanistic target of rapamycin inhibitor, has emerged as a promising systemic therapy for venous malformations, with growing evidence supporting its use in BRBNS across pediatric and adult populations. We report the long-term course of a male patient with BRBNS who first presented in early childhood with progressive visceral lesions and chronic anemia. He demonstrated significant clinical improvement with sirolimus therapy, with recurrence of profound anemia during a period of adolescent nonadherence. Now in his early 20s, he remains clinically stable on maintenance therapy. This case highlights the durability of sirolimus response, the risks of interruption, and the importance of long-term adherence.
2026-08-28 | Gastrointestinal Blue Rubber Bleb Nevus Syndrome in Children: A Case Series Across Endoscopic, Surgical, and Medical Management.
Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare venous malformation disorder causing recurrent gastrointestinal bleeding and severe anemia. We report three children illustrating endoscopic, surgical, and medical management. All presented with melena and transfusion-requiring anemia. Case 1 developed gastric perforation after endoscopic band ligation and underwent emergency primary repair with bowel-preserving excision of accessible lesions, followed by recovery. Case 2 had more than 100 gastrointestinal lesions and underwent lesion-directed wedge resections, achieving transfusion independence and hemoglobin normalization at 1 year. Case 3 had idiopathic extrahepatic portal vein obstruction, portal hypertension, and diffuse mesenteric disease that was not safely resectable; sirolimus was initiated, but intermittent bleeding and transfusion dependence persisted. Management should be individualized according to lesion burden, anatomical extent, procedural risk, and feasibility of bowel-preserving treatment. Surgery remains important for complications and resectable disease, whereas systemic therapy may be required for diffuse unresectable involvement.
2026-08-13 | A high-sensitivity TIE2-GRB2 BRET platform for functional and pharmacologic profiling of pathogenic variants associated with venous malformations.
TIE2 is an endothelial receptor tyrosine kinase (RTK) essential for vascular integrity, and constitutively active TIE2 mutants are involved in venous malformations (VMs). VMs are currently treated by surgery or sclerotherapy, but effective pharmacologic options remain limited, especially for surgically challenging Blue Rubber Bleb Nevus Syndrome (BRBNS). TIE2 activation has typically been assessed by immunoblotting of phosphoproteins, yet scalable assays applicable to pharmacological evaluation are still lacking. Here, we present a bioluminescence resonance energy transfer (BRET) biosensor that quantifies receptor-proximal TIE2 activation by monitoring recruitment of GRB2, a major adaptor in RTK signaling. This BRET sensor detects angiopoietin-1 (ANG-1) at physiological plasma concentrations and is compatible with a high-throughput format. Furthermore, it captures constitutive activity of TIE2 mutants associated with VMs and enables pharmacological evaluation of TIE2 variants. Notably, the T1105N-T1106P variant, frequently observed in BRBNS, exhibited relatively higher sensitivity to the clinical oncology drugs regorafenib and lenvatinib. To validate selected BRET-defined pharmacological profiles in an endothelial context, we used HUVEC-derived HUEhT-2 cells and established endothelial TIE2-GRB2 BRET measurements, followed by downstream AKT/ERK signaling analysis and tube formation assays. These endothelial assays largely supported the selected HEK293T BRET findings, particularly the pharmacological profile of T1105N-T1106P mutant, at receptor-proximal, downstream signaling, and functional levels. Together, this BRET-based biosensor establishes a two-step framework: HEK293T BRET enables efficient primary profiling, whereas endothelial assays provide orthogonal validation to support biological interpretation. This framework offers a practical strategy for prioritizing pharmacological candidates for further endothelial and in vivo validation toward therapeutic development.
antibodies
2026-02-18 | Cerebrovascular Malformations Associated With Hereditary Hemorrhagic Telangiectasia and HHT-Like Syndromes: A Comparative Overview.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder marked by mucocutaneous telangiectasias, recurrent epistaxis, and visceral arteriovenous malformations (AVMs). Neurologic risks include brain AVMs and hemorrhagic stroke. Several rare genetic and sporadic syndromes ("HHT-like" syndromes) share overlapping vascular features, complicating diagnosis. Differentiating these conditions is essential for accurate neurovascular risk assessment. A comprehensive literature review (PubMed, Scopus, Embase, Google Scholar; 1990-2025) targeted cerebrovascular manifestations of HHT and related syndromes. Key entities included Wyburn-Mason syndrome, Cobb syndrome, Klippel-Trénaunay syndrome (KTS), neurofibromatosis type 1 (NF1), PHACE(S) syndrome, capillary malformation-AVM (CM-AVM), Parkes Weber syndrome (PWS), juvenile polyposis/HHT overlap (JP-HHT), HHT type 5 (BMP9/GDF2), PTEN hamartoma tumor syndrome (PHTS), and blue rubber bleb nevus syndrome (BRBNS). Data on gene variants, lesion types, neuroimaging, stroke risk, and neurologic outcomes were synthesized. High-flow cerebrovascular malformations similar to HHT are prominent in Wyburn-Mason syndrome, CM-AVM, and PWS, conferring a substantial hemorrhagic stroke risk. NF1 and PHACE(S) primarily feature occlusive arteriopathies linked to ischemic events. KTS, BRBNS, and PHTS predominantly show low- or mixed-flow anomalies with lower CNS hemorrhagic risk but increased thrombotic complications. JP-HHT carries added gastrointestinal cancer risk via SMAD4 variants, while HHT type 5 often presents incompletely. Genetic testing and tailored neuroimaging are critical for differentiation. Although many syndromes mimic HHT, few combine mucosal telangiectasias, high-flow AVMs, and recurrent hemorrhage. Integrating clinical, imaging, and genetic data enables precise diagnosis, risk stratification, and personalized management.
2026-01-29 | Clinical application of capsule endoscopy in children with small bowel disease in Wuhan, China.
To evaluate the clinical application value of capsule endoscopy (CE) in the diagnosis of small intestinal diseases in children in Wuhan. A retrospective analysis was conducted on the clinical data of children who underwent CE examination at the Digestive Endoscopy Center of Wuhan Children's Hospital from July 2021 to November 2024. The completion rate of CE examination, disease detection rate, small intestinal transit time, and adverse reactions were analyzed. Among the 151 children, 97 were male (64.24%) and 54 were female (35.76%), with an average age of 10.9 years. CE was swallowed orally in 133 cases (88.08%) and placed through gastroscopy in 18 cases (11.92%). Complete small intestinal examination was achieved in 144 cases (95.36%), with an average small intestinal transit time of 4 h and 11 min for those swallowed orally and 4 h and 16 min for those placed through gastroscopy. Seven cases (4.64%) did not complete the full small intestinal examination. Abdominal pain (99 cases, 65.56%), anemia (19 cases, 12.58%), and hematochezia and melena (23 cases, 15.23%) were the most common indications for examination. Among the 151 children, 116 (76.82%) had positive results, including 68 cases of nonspecific small intestinal inflammation, 29 cases of Crohn's disease, 4 cases of Henoch-Schönlein purpura, 6 cases of Meckel's diverticulum, 4 cases of small intestinal parasitic disease, 2 cases of collagenous gastritis, 1 case of melanocytic polyp, 1 case of lymphangiectasia, and 1 case of blue rubber bleb nevus syndrome. Nonspecific small intestinal inflammation was the most common in all age groups, while Crohn's disease was mainly seen in the 7-12 years and 13-18 years age groups, accounting for 55.17% and 44.83%, respectively. No adverse reactions occurred in all children. CE examination in children in Wuhan has a high disease detection rate and good safety. CE can be further promoted in the diagnosis of small intestinal diseases in children.
2025-12-26 | Artificial Intelligence in Cosmetic Dermatology with Regard to Laser Treatments: A Comparative Analysis of AI and Dermatologists’ Decision-Making
Introduction: Artificial intelligence (AI) has developed into an increasingly important tool in dermatology. While new technologies integrated within laser devices are emerging, there is a lack of data on the applicability of publicly available AI models. Methods: The prospective study used an online questionnaire where participants evaluated diagnosis and treatment for 25 dermatological cases shown as pictures. The same questions were given to AI models: ChatGPT-4o, Claude Sonnet 4, Gemini 2.5 Flash, and Grok-3. Results: Dermatologists outperformed AI in diagnostic accuracy (suspected primary diagnosis-SD 75.6%) in pooled dermatologists vs. pooled AI (SD 57.0%), with laser specialists achieving the highest accuracy (SD 82.0%) and residents the lowest (SD 66.0%). There was a high heterogeneity across AI models. Gemini approached dermatologist performance (SD 72.0%), while Claude showed a low accuracy (SD 40.0%). While AI models reached near 100% accuracy in some classic/common diagnoses (e.g., acne, rosacea, spider angioma, infantile hemangioma), their accuracy dropped to near 0% on rare or context-dependent cases (e.g., blue rubber bleb nevus syndrome, angiosarcoma, hirsutism, cutaneous siderosis). Inter-rater agreement was high among laser experts in terms of diagnostic accuracy and treatment choice. Agreement between residents and AI models was highest for diagnostic accuracy and treatment choice, while it was lowest between experts and AI models. Conclusions: Before AI-based tools can be integrated into daily practice, particularly regarding diagnosis and appropriate laser treatment recommendations, specific supervised medical training of the AI model is necessary, as open-source platforms currently lack the ability to contextualize presented data.
2025-12-19 | P17 Distinguishing familial generalized multiple glomangiomas from blue rubber bleb naevus syndrome: a case discussion.
A 14-year-old, boy was referred with three mildly tender, blue papulonodular vascular lesions located on his left knee, right flank, and left scapula. The lesions on his knee and flank had been present since birth, but he reported recent onset of the lesion on his left scapula. His mother and maternal grandfather reported similar lesions on their leg and forehead. The differential diagnosis included blue rubber bleb nevus (BRBN) syndrome. However, a punch biopsy revealed changes consistent with glomangioma: vascular channels surrounded by bland cells with uniform nuclei that, on immunohistochemistry, exhibited diffuse positivity for SMA and Calponin. This, together with the clinical picture, confirmed a diagnosis of familial generalised multiple glomangiomas (FGMG). This case provides an opportunity to compare the similarities and differences between BRBN and FGMG. While BRBN is usually sporadic, autosomal dominant inheritance can occur. In contrast, FGMG is typically autosomal dominant with incomplete penetrance.1 Both conditions share similar clinical features, presenting with multiple, blue vascular papulonodular lesions that are typically congenital but may increase in number and size, particularly during puberty.2 While generally painless, discomfort or pain may be reported.1 Accurate diagnosis is essential because, although lesions in FGMG are typically limited to the skin, BRBN lesions frequently involve extracutaneous sites-most notably the gastrointestinal tract-where they can lead to significant complications such as haemorrhage or intussusception.2 Confirmation of the diagnosis of FGMG enables reassurance for patients and their families and avoids the requirement for endoscopy and life-long follow-up.
2025-06-27 | Venous malformations as a rare cause of lower gastrointestinal bleeding in a young patient with Blue Rubber Bleb Nevus Syndrome
We report a case of 19-year-old male who presented with complaints of recurrent episodes of passage of black coloured stools since last 2 weeks. The patient reported that he had multiple blue coloured lesions in hands, legs and face since childhood. At physical examination, the lesions were of variable sizes ranging from 3-10 mm and resembled small bubbles of blue colouration. Biopsy taken from one of the lesions in childhood was suggestive of cavernous haemangioma. Laboratory investigations revealed microcytic anaemia (haemoglobin 9 g/dL; serum ferritin 22ng/ ml; transferrin saturation 10%) with normal rest of the laboratory parameters. His stool sample tested positive for occult blood. Further colonoscopy done to look for the origin of bleed revealed multiple, variable sized vascular malformations involving the colon and visualized distal 10 cm of terminal ileum without any active bleed. Gastroscopy revealed multiple vascular malformations in the stomach and second part of duodenum.
small molecules
2026-09-25 | When lesion-directed therapy is not enough: blue rubber bleb nevus syndrome in a young adult-a case report.
Blue rubber bleb nevus syndrome (BRBNS) is a rare systemic venous malformation disorder that primarily affects the skin and gastrointestinal tract. We report a 20-year-old Chinese man of Han ethnicity with multifocal cutaneous and soft-tissue venous malformations and recurrent gastrointestinal bleeding since early childhood. Despite repeated endoscopic and surgical interventions, he developed recurrent melena, hematochezia, and severe anemia requiring transfusion. During the current hospitalization, he received packed red-cell transfusion and oral iron supplementation and underwent lauromacrogol sclerotherapy of multiple symptomatic soft-tissue venous malformations. His hemoglobin level increased from 55 to 98 g/L at discharge, and no recurrent gastrointestinal bleeding occurred during 2 months of follow-up. This case illustrates the limitations of repeated lesion-directed therapy in multifocal BRBNS and emphasizes the importance of multidisciplinary management and longitudinal surveillance. Although early clinical and hematologic improvement was observed, longer follow-up is required to determine whether durable disease control has been achieved.
2026-09-09 | Blue rubber bleb nevus syndrome as an uncommon cause of gastrointestinal overt bleeding: a diagnostic and therapeutic challenge.
A 76-year-old woman on anticoagulation for atrial fibrillation presented with melaena. Her medical history included previous jejunal resection, aortic aneurysm repair, and cervical cancer in remission. Initial upper gastrointestinal endoscopy and complete colonoscopy showed no source of bleeding. Despite discontinuation of anticoagulation, she developed recurrent gastrointestinal bleeding with severe transfusion-dependent anaemia. Capsule endoscopy demonstrated bluish submucosal vascular lesions in the jejunum, suggestive of Blue Rubber Bleb Nevus Syndrome (BRBNS), a diagnosis further supported by dermatological findings. Single-balloon enteroscopy revealed multiple jejunal venous blebs, with no active bleeding, throughout the first 240 cm of examined small bowel. Treatment with somatostatin and sirolimus was started; however, ongoing bleeding and clinical instability prompted an enteroscopy-guided surgical strategy. At laparotomy, multiple subserosal jejunal lesions were identified, corresponding to the endoscopic findings. A 20-cm bleeding jejunal segment was resected, followed by end-to-end anastomosis, with preservation of 250 cm of jejunum. BRBNS, also known as Bean syndrome, is a rare vascular malformation disorder characterised by multiple venous malformations, most commonly affecting the skin and gastrointestinal tract. Gastrointestinal involvement may lead to chronic occult bleeding, recurrent overt haemorrhage, iron-deficiency anaemia, and transfusion dependence. Current evidence is largely limited to case reports and small series, making management challenging. Endoscopic therapy is generally preferred when lesions are accessible, but extensive or multifocal small-bowel disease may limit its effectiveness. Sirolimus has shown promising results as systemic therapy, although its delayed onset of action may be unsuitable in patients with severe ongoing haemorrhage or clinical instability. This case highlights the value of capsule endoscopy and device-assisted enteroscopy not only for diagnosing small-bowel BRBNS, but also for guiding bowel-sparing surgery when endoscopic treatment is insufficient and systemic therapy cannot provide timely haemorrhage control.
2026-09-01 | Transitioning Care in Blue Rubber Bleb Nevus Syndrome
Blue rubber bleb nevus syndrome (BRBNS) is a rare venous malformation disorder characterized by multifocal cutaneous and visceral lesions, most commonly involving the gastrointestinal tract. These lesions may cause chronic occult bleeding, iron-deficiency anemia, pain crises, and occasionally life-threatening hemorrhage. Sirolimus, an mechanistic target of rapamycin inhibitor, has emerged as a promising systemic therapy for venous malformations, with growing evidence supporting its use in BRBNS across pediatric and adult populations. We report the long-term course of a male patient with BRBNS who first presented in early childhood with progressive visceral lesions and chronic anemia. He demonstrated significant clinical improvement with sirolimus therapy, with recurrence of profound anemia during a period of adolescent nonadherence. Now in his early 20s, he remains clinically stable on maintenance therapy. This case highlights the durability of sirolimus response, the risks of interruption, and the importance of long-term adherence.
2026-08-28 | Gastrointestinal Blue Rubber Bleb Nevus Syndrome in Children: A Case Series Across Endoscopic, Surgical, and Medical Management.
Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare venous malformation disorder causing recurrent gastrointestinal bleeding and severe anemia. We report three children illustrating endoscopic, surgical, and medical management. All presented with melena and transfusion-requiring anemia. Case 1 developed gastric perforation after endoscopic band ligation and underwent emergency primary repair with bowel-preserving excision of accessible lesions, followed by recovery. Case 2 had more than 100 gastrointestinal lesions and underwent lesion-directed wedge resections, achieving transfusion independence and hemoglobin normalization at 1 year. Case 3 had idiopathic extrahepatic portal vein obstruction, portal hypertension, and diffuse mesenteric disease that was not safely resectable; sirolimus was initiated, but intermittent bleeding and transfusion dependence persisted. Management should be individualized according to lesion burden, anatomical extent, procedural risk, and feasibility of bowel-preserving treatment. Surgery remains important for complications and resectable disease, whereas systemic therapy may be required for diffuse unresectable involvement.
2026-08-13 | A high-sensitivity TIE2-GRB2 BRET platform for functional and pharmacologic profiling of pathogenic variants associated with venous malformations.
TIE2 is an endothelial receptor tyrosine kinase (RTK) essential for vascular integrity, and constitutively active TIE2 mutants are involved in venous malformations (VMs). VMs are currently treated by surgery or sclerotherapy, but effective pharmacologic options remain limited, especially for surgically challenging Blue Rubber Bleb Nevus Syndrome (BRBNS). TIE2 activation has typically been assessed by immunoblotting of phosphoproteins, yet scalable assays applicable to pharmacological evaluation are still lacking. Here, we present a bioluminescence resonance energy transfer (BRET) biosensor that quantifies receptor-proximal TIE2 activation by monitoring recruitment of GRB2, a major adaptor in RTK signaling. This BRET sensor detects angiopoietin-1 (ANG-1) at physiological plasma concentrations and is compatible with a high-throughput format. Furthermore, it captures constitutive activity of TIE2 mutants associated with VMs and enables pharmacological evaluation of TIE2 variants. Notably, the T1105N-T1106P variant, frequently observed in BRBNS, exhibited relatively higher sensitivity to the clinical oncology drugs regorafenib and lenvatinib. To validate selected BRET-defined pharmacological profiles in an endothelial context, we used HUVEC-derived HUEhT-2 cells and established endothelial TIE2-GRB2 BRET measurements, followed by downstream AKT/ERK signaling analysis and tube formation assays. These endothelial assays largely supported the selected HEK293T BRET findings, particularly the pharmacological profile of T1105N-T1106P mutant, at receptor-proximal, downstream signaling, and functional levels. Together, this BRET-based biosensor establishes a two-step framework: HEK293T BRET enables efficient primary profiling, whereas endothelial assays provide orthogonal validation to support biological interpretation. This framework offers a practical strategy for prioritizing pharmacological candidates for further endothelial and in vivo validation toward therapeutic development.
antibodies
2026-02-18 | Cerebrovascular Malformations Associated With Hereditary Hemorrhagic Telangiectasia and HHT-Like Syndromes: A Comparative Overview.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder marked by mucocutaneous telangiectasias, recurrent epistaxis, and visceral arteriovenous malformations (AVMs). Neurologic risks include brain AVMs and hemorrhagic stroke. Several rare genetic and sporadic syndromes ("HHT-like" syndromes) share overlapping vascular features, complicating diagnosis. Differentiating these conditions is essential for accurate neurovascular risk assessment. A comprehensive literature review (PubMed, Scopus, Embase, Google Scholar; 1990-2025) targeted cerebrovascular manifestations of HHT and related syndromes. Key entities included Wyburn-Mason syndrome, Cobb syndrome, Klippel-Trénaunay syndrome (KTS), neurofibromatosis type 1 (NF1), PHACE(S) syndrome, capillary malformation-AVM (CM-AVM), Parkes Weber syndrome (PWS), juvenile polyposis/HHT overlap (JP-HHT), HHT type 5 (BMP9/GDF2), PTEN hamartoma tumor syndrome (PHTS), and blue rubber bleb nevus syndrome (BRBNS). Data on gene variants, lesion types, neuroimaging, stroke risk, and neurologic outcomes were synthesized. High-flow cerebrovascular malformations similar to HHT are prominent in Wyburn-Mason syndrome, CM-AVM, and PWS, conferring a substantial hemorrhagic stroke risk. NF1 and PHACE(S) primarily feature occlusive arteriopathies linked to ischemic events. KTS, BRBNS, and PHTS predominantly show low- or mixed-flow anomalies with lower CNS hemorrhagic risk but increased thrombotic complications. JP-HHT carries added gastrointestinal cancer risk via SMAD4 variants, while HHT type 5 often presents incompletely. Genetic testing and tailored neuroimaging are critical for differentiation. Although many syndromes mimic HHT, few combine mucosal telangiectasias, high-flow AVMs, and recurrent hemorrhage. Integrating clinical, imaging, and genetic data enables precise diagnosis, risk stratification, and personalized management.
2026-01-29 | Clinical application of capsule endoscopy in children with small bowel disease in Wuhan, China.
To evaluate the clinical application value of capsule endoscopy (CE) in the diagnosis of small intestinal diseases in children in Wuhan. A retrospective analysis was conducted on the clinical data of children who underwent CE examination at the Digestive Endoscopy Center of Wuhan Children's Hospital from July 2021 to November 2024. The completion rate of CE examination, disease detection rate, small intestinal transit time, and adverse reactions were analyzed. Among the 151 children, 97 were male (64.24%) and 54 were female (35.76%), with an average age of 10.9 years. CE was swallowed orally in 133 cases (88.08%) and placed through gastroscopy in 18 cases (11.92%). Complete small intestinal examination was achieved in 144 cases (95.36%), with an average small intestinal transit time of 4 h and 11 min for those swallowed orally and 4 h and 16 min for those placed through gastroscopy. Seven cases (4.64%) did not complete the full small intestinal examination. Abdominal pain (99 cases, 65.56%), anemia (19 cases, 12.58%), and hematochezia and melena (23 cases, 15.23%) were the most common indications for examination. Among the 151 children, 116 (76.82%) had positive results, including 68 cases of nonspecific small intestinal inflammation, 29 cases of Crohn's disease, 4 cases of Henoch-Schönlein purpura, 6 cases of Meckel's diverticulum, 4 cases of small intestinal parasitic disease, 2 cases of collagenous gastritis, 1 case of melanocytic polyp, 1 case of lymphangiectasia, and 1 case of blue rubber bleb nevus syndrome. Nonspecific small intestinal inflammation was the most common in all age groups, while Crohn's disease was mainly seen in the 7-12 years and 13-18 years age groups, accounting for 55.17% and 44.83%, respectively. No adverse reactions occurred in all children. CE examination in children in Wuhan has a high disease detection rate and good safety. CE can be further promoted in the diagnosis of small intestinal diseases in children.
2025-12-26 | Artificial Intelligence in Cosmetic Dermatology with Regard to Laser Treatments: A Comparative Analysis of AI and Dermatologists’ Decision-Making
Introduction: Artificial intelligence (AI) has developed into an increasingly important tool in dermatology. While new technologies integrated within laser devices are emerging, there is a lack of data on the applicability of publicly available AI models. Methods: The prospective study used an online questionnaire where participants evaluated diagnosis and treatment for 25 dermatological cases shown as pictures. The same questions were given to AI models: ChatGPT-4o, Claude Sonnet 4, Gemini 2.5 Flash, and Grok-3. Results: Dermatologists outperformed AI in diagnostic accuracy (suspected primary diagnosis-SD 75.6%) in pooled dermatologists vs. pooled AI (SD 57.0%), with laser specialists achieving the highest accuracy (SD 82.0%) and residents the lowest (SD 66.0%). There was a high heterogeneity across AI models. Gemini approached dermatologist performance (SD 72.0%), while Claude showed a low accuracy (SD 40.0%). While AI models reached near 100% accuracy in some classic/common diagnoses (e.g., acne, rosacea, spider angioma, infantile hemangioma), their accuracy dropped to near 0% on rare or context-dependent cases (e.g., blue rubber bleb nevus syndrome, angiosarcoma, hirsutism, cutaneous siderosis). Inter-rater agreement was high among laser experts in terms of diagnostic accuracy and treatment choice. Agreement between residents and AI models was highest for diagnostic accuracy and treatment choice, while it was lowest between experts and AI models. Conclusions: Before AI-based tools can be integrated into daily practice, particularly regarding diagnosis and appropriate laser treatment recommendations, specific supervised medical training of the AI model is necessary, as open-source platforms currently lack the ability to contextualize presented data.
2025-12-19 | P17 Distinguishing familial generalized multiple glomangiomas from blue rubber bleb naevus syndrome: a case discussion.
A 14-year-old, boy was referred with three mildly tender, blue papulonodular vascular lesions located on his left knee, right flank, and left scapula. The lesions on his knee and flank had been present since birth, but he reported recent onset of the lesion on his left scapula. His mother and maternal grandfather reported similar lesions on their leg and forehead. The differential diagnosis included blue rubber bleb nevus (BRBN) syndrome. However, a punch biopsy revealed changes consistent with glomangioma: vascular channels surrounded by bland cells with uniform nuclei that, on immunohistochemistry, exhibited diffuse positivity for SMA and Calponin. This, together with the clinical picture, confirmed a diagnosis of familial generalised multiple glomangiomas (FGMG). This case provides an opportunity to compare the similarities and differences between BRBN and FGMG. While BRBN is usually sporadic, autosomal dominant inheritance can occur. In contrast, FGMG is typically autosomal dominant with incomplete penetrance.1 Both conditions share similar clinical features, presenting with multiple, blue vascular papulonodular lesions that are typically congenital but may increase in number and size, particularly during puberty.2 While generally painless, discomfort or pain may be reported.1 Accurate diagnosis is essential because, although lesions in FGMG are typically limited to the skin, BRBN lesions frequently involve extracutaneous sites-most notably the gastrointestinal tract-where they can lead to significant complications such as haemorrhage or intussusception.2 Confirmation of the diagnosis of FGMG enables reassurance for patients and their families and avoids the requirement for endoscopy and life-long follow-up.
2025-06-27 | Venous malformations as a rare cause of lower gastrointestinal bleeding in a young patient with Blue Rubber Bleb Nevus Syndrome
We report a case of 19-year-old male who presented with complaints of recurrent episodes of passage of black coloured stools since last 2 weeks. The patient reported that he had multiple blue coloured lesions in hands, legs and face since childhood. At physical examination, the lesions were of variable sizes ranging from 3-10 mm and resembled small bubbles of blue colouration. Biopsy taken from one of the lesions in childhood was suggestive of cavernous haemangioma. Laboratory investigations revealed microcytic anaemia (haemoglobin 9 g/dL; serum ferritin 22ng/ ml; transferrin saturation 10%) with normal rest of the laboratory parameters. His stool sample tested positive for occult blood. Further colonoscopy done to look for the origin of bleed revealed multiple, variable sized vascular malformations involving the colon and visualized distal 10 cm of terminal ileum without any active bleed. Gastroscopy revealed multiple vascular malformations in the stomach and second part of duodenum.
Access all drug discovery papers and probability of success in trials forecasts:
Access all drug discovery papers and probability of success in trials forecasts:
Drug Discovery Landscape
0 orphan drug designations.
0 orphan drug designations.
Let's accelerate rare disease drug discovery
Let's accelerate drug discovery
Get access to Explority AI’s forecasts to outperform average preclinical success rates. Whether you’re expanding your R&D pipeline, evaluating a partnership, or simply have a question — we’d love to hear from you.